中投顧問重磅推出產業研究大腦，是"產業研究的數字化高效工具"，歡迎試用體驗！ | ||||
|---|---|---|---|---|
| 產品名稱 | 目標用戶 | 核心功能定位 | 產品介紹 | 試用申請 |
| 產業研究大腦 | 政府、企業內關注產業發展的領導及工作人員 | 產業研究工作的一站式解決方案 | 詳情 > | 申請 > |
聯系電話： 400 008 0586; 0755-82571568
微信掃碼： 
1.EXECUTIVESUMMARY
·ExecutiveSummary
Introduction
2.MARKETINTRODUCTION
·Overview
ScopeandSegmentation
ResearchMethodology
·DiseaseOverview
Asthma
COPD
TreatmentOptions
·MarketOverview
MarketEngineeringMeasurements
IndustryChallengesandStrategicRecommendations
MarketDrivers
MarketRestraints
3.TOTALMARKETANALYSIS
·CompetitiveAnalysis
CompetitiveStructure
·PatientForecasts
PatientForecasts-Asthma
PatientForecasts-COPD
TotalPatientForecasts
·RevenueForecasts
TotalMarketRevenueForecasts
MarketShareAnalysis
4.BRONCHODILATORSMARKET
·Introduction
Introduction
MarketEngineeringMeasurements
RevenueForecasts
MarketShareAnalysis
·Short-ActingBeta-2AgonistsMarket
Introduction
RevenueForecasts
ProductAnalysis
PipelineAnalysis
·Long-ActingBeta-2AgonistsMarket
Introduction
RevenueForecasts
ProductAnalysis
PipelineAnalysis
·AnticholinergicsMarket
Introduction
RevenueForecasts
ProductAnalysis
PipelineAnalysis
·CombinationBronchodilators
Introduction
RevenueForecasts
ProductAnalysis
PipelineAnalysis
5.ANTI-INFLAMMATORYMARKET
·Introduction
Introduction
MarketEngineeringMeasurements
RevenueForecasts
MarketShareAnalysis
·InhaledCorticosteroidsMarket
Introduction
RevenueForecasts
ProductAnalysis
PipelineAnalysis
·Mediator-ReleaseInhibitorMarket
Introduction
RevenueForecasts
ProductAnalysis
PipelineAnalysis
·Anti-LeukotrieneMarket
Introduction
RevenueForecasts
PipelineAnalysis
·MonoclonalAntibodyMarket
Introduction
RevenueForecasts
PipelineAnalysis
·OtherEmergingAnti-Inflammatories
PipelineAnalysis
6.COMBINATIONTHERAPIESMARKET
·CombinationTherapies
Introduction
MarketEngineeringMeasurements
RevenueForecasts
ProductAnalysis
7.APPENDIX
·DecisionSupportDatabases
MortalityDuetoAsthmaBronchitisandEmphysema
PrevalenceofAsthma
PrevalenceofChronicObstructivePulmonaryDisease
FemalePopulation65andAbove
MalePopulation65andAbove
This research service covers the U.S. asthma/COPD market from 2003-2013. Included are a therapeutic overview, patient forecasts, total market revenue forecasts, market segment revenue forecasts, and market share analysis. The market is segmented by product class: bronchodilators, anti-inflammatories, and combination therapies. Major market challenges, drivers, restraints, and strategic recommendations to overcome market challenges are also discussed.
